MedTrace Logo

Trial on Profermin and Fresubin in Ulcerative Colitis

NCT01193894 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2013-12-17

No results posted yet for this study

Summary

This study aim to investigate the effect of Profermin versus Fresubin in the dietetic treatment of active ulcerative colitis.

Conditions

Interventions

OTHER

Profermin

Medical Food (food for special medical purposes)

OTHER

Fresubin

Medical food (food for special medical purposes)

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • Nordisk Rebalance A/S

    lead INDUSTRY

Principal Investigators

  • Hans Israelsen, PhD · Nordisk Rebalance A/S

  • Aleksander Krag, MD, PhD · Hvidovre University Hospital

  • Flemming Bendtsen, MD, DMSci · Hvidovre University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01193894 on ClinicalTrials.gov